129 related articles for article (PubMed ID: 12534979)
1. Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice.
Castañé A; Robledo P; Matifas A; Kieffer BL; Maldonado R
Eur J Neurosci; 2003 Jan; 17(1):155-9. PubMed ID: 12534979
[TBL] [Abstract][Full Text] [Related]
2. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors.
Ghozland S; Matthes HW; Simonin F; Filliol D; Kieffer BL; Maldonado R
J Neurosci; 2002 Feb; 22(3):1146-54. PubMed ID: 11826143
[TBL] [Abstract][Full Text] [Related]
3. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
4. Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice.
Simonin F; Slowe S; Becker JA; Matthes HW; Filliol D; Chluba J; Kitchen I; Kieffer BL
Eur J Pharmacol; 2001 Mar; 414(2-3):189-95. PubMed ID: 11239918
[TBL] [Abstract][Full Text] [Related]
5. Adenosine A2A receptors are involved in physical dependence and place conditioning induced by THC.
Soria G; Castañé A; Berrendero F; Ledent C; Parmentier M; Maldonado R; Valverde O
Eur J Neurosci; 2004 Oct; 20(8):2203-13. PubMed ID: 15450100
[TBL] [Abstract][Full Text] [Related]
6. Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice.
Valverde O; Maldonado R; Valjent E; Zimmer AM; Zimmer A
J Neurosci; 2000 Dec; 20(24):9284-9. PubMed ID: 11125007
[TBL] [Abstract][Full Text] [Related]
7. Mu and delta opioid receptor knockout mice show increased colonic sensitivity.
Reiss D; Ceredig RA; Secher T; Boué J; Barreau F; Dietrich G; Gavériaux-Ruff C
Eur J Pain; 2017 Apr; 21(4):623-634. PubMed ID: 27748566
[TBL] [Abstract][Full Text] [Related]
8. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
Solinas M; Goldberg SR
Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
[TBL] [Abstract][Full Text] [Related]
9. Acute antinociceptive responses in single and combinatorial opioid receptor knockout mice: distinct mu, delta and kappa tones.
Martin M; Matifas A; Maldonado R; Kieffer BL
Eur J Neurosci; 2003 Feb; 17(4):701-8. PubMed ID: 12603260
[TBL] [Abstract][Full Text] [Related]
10. Improgan, a cimetidine analog, induces morphine-like antinociception in opioid receptor-knockout mice.
Hough LB; Nalwalk JW; Chen Y; Schuller A; Zhu Y; Zhang J; Menge WM; Leurs R; Timmerman H; Pintar JE
Brain Res; 2000 Oct; 880(1-2):102-8. PubMed ID: 11032994
[TBL] [Abstract][Full Text] [Related]
11. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence.
González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA
Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659
[TBL] [Abstract][Full Text] [Related]
12. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
13. Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice.
Balerio GN; Aso E; Berrendero F; Murtra P; Maldonado R
Eur J Neurosci; 2004 Nov; 20(10):2737-48. PubMed ID: 15548217
[TBL] [Abstract][Full Text] [Related]
14. Parallel Synthesis of Hexahydrodiimidazodiazepines Heterocyclic Peptidomimetics and Their in Vitro and in Vivo Activities at μ (MOR), δ (DOR), and κ (KOR) Opioid Receptors.
Eans SO; Ganno ML; Mizrachi E; Houghten RA; Dooley CT; McLaughlin JP; Nefzi A
J Med Chem; 2015 Jun; 58(12):4905-17. PubMed ID: 25996309
[TBL] [Abstract][Full Text] [Related]
15. Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect.
Valverde O; Noble F; Beslot F; Daugé V; Fournié-Zaluski MC; Roques BP
Eur J Neurosci; 2001 May; 13(9):1816-24. PubMed ID: 11359533
[TBL] [Abstract][Full Text] [Related]
16. The behavioral effects of a mixed efficacy antinociceptive peptide, VRP26, following chronic administration in mice.
Anand JP; Boyer BT; Mosberg HI; Jutkiewicz EM
Psychopharmacology (Berl); 2016 Jul; 233(13):2479-87. PubMed ID: 27117141
[TBL] [Abstract][Full Text] [Related]
17. Characterization of mechanical withdrawal responses and effects of mu-, delta- and kappa-opioid agonists in normal and mu-opioid receptor knockout mice.
Fuchs PN; Roza C; Sora I; Uhl G; Raja SN
Brain Res; 1999 Mar; 821(2):480-6. PubMed ID: 10064835
[TBL] [Abstract][Full Text] [Related]
18. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.
Welch SP; Dunlow LD; Patrick GS; Razdan RK
J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096
[TBL] [Abstract][Full Text] [Related]
19. Brain regional Fos expression elicited by the activation of mu- but not delta-opioid receptors of the ventral tegmental area: evidence for an implication of the ventral thalamus in opiate reward.
David V; Matifas A; Gavello-Baudy S; Decorte L; Kieffer BL; Cazala P
Neuropsychopharmacology; 2008 Jun; 33(7):1746-59. PubMed ID: 17895918
[TBL] [Abstract][Full Text] [Related]
20. Activation of delta-opioid receptor contributes to the antinociceptive effect of oxycodone in mice.
Yang PP; Yeh GC; Yeh TK; Xi J; Loh HH; Law PY; Tao PL
Pharmacol Res; 2016 Sep; 111():867-876. PubMed ID: 27496654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
